相关实验视频
Updated: Jul 4, 2025

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.7K
在急性大血管阻塞中血静分子标记物的改变中风
Xin Xu1,2,3, Yiming Song1,2, Wenbo Cao1,2
1Department of Neurosurgery, Xuanwu Hospital Capital Medical University Beijing China.
Journal of the American Heart Association
|January 31, 2024
概括
凝血和纤维溶解的标志物,包括血栓-抗血栓复合物 (TAT) 和等离子体-α2等离子体抑制剂复合物 (PIC),在急性中风患者的缺血区域中升高. 这些标记物有助于预测中风并发症和结果.
科学领域:
- 生物化学 生物化学
- 血管生物学 血管生物学
- 脑卒中医学 脑卒中医学
背景情况:
- 急性缺血性中风 (AIS) 涉及复杂的静血变化.
- 血管内血栓切除术 (EVT) 是AIS的关键治疗方法.
- 了解AIS的区域静血变化对于风险分层至关重要.
研究的目的:
- 在接受EVT的AIS患者中调查特定的静血标志物的区域水平.
- 确定这些标记物与临床和程序特征的关联.
- 评估这些标志物对中风并发症和结果的预测价值.
主要方法:
- 对166名接受EVT的AIS患者进行了回顾性分析.
- 在局部缺血和全身动脉血液中测量TAT,PIC,t-PAIC,sTM和D-二次体.
- 统计分析以将标志物水平与症状性内出血以及90天的结果相关联.
主要成果:
- 与全身水平相比,TAT,PIC,t-PAIC和D-二次体在局部缺血区域上升.
- 升高的缺血TAT和PIC与症状性内出血的风险增加相关.
- 增加的缺血TAT,PIC和sTM与不良的90天结果有关.
- 静血标志物显著提高了传统风险因素的预测能力.
结论:
- 在超急性中风期间,在局部缺血区域存在过度活跃的凝血-纤维化系统.
- 快速测量TAT,PIC和sTM可能有助于中风风险分层和治疗决策.
- 对这些静血标志物的进一步调查是有必要的.
相关概念视频
Introduction to Hemostasis
7.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.8K
Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Disorders of Hemostasis
915
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
915

